Generics Bulletin is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Accord Takes A Trio Of Awards

As A Host Of Leading Off-Patent Industry Firms Also Rewarded

Executive Summary

Accord Healthcare took home a trio of prizes at the Global Generics & Biosimilars Awards 2020, with other winners including Alvogen, Aurobindo, Dr Reddy’s, Eurofarma, Insud Pharma, Macleods, Pinsent Masons, Samsung Bioepis, Sandoz, Stada and Zentiva.

You may also be interested in...



International Health Partners Urges Integrated Approach To Donations And CSR

Generics firms are increasingly adopting a more integrated approach to corporate social responsibility activities, including product donations, as part of their strategy as they work alongside organizations such as International Health Partners, the charity’s CEO Adele Paterson tells Generics Bulletin.

Sandoz’ Saynor Insists On Value Of ‘Pure Play’ Approach

Sandoz is benefiting from its focus on a “pure play” generics and biosimilars model that is unique among its peers, CEO Richard Saynor tells Generics Bulletin in an exclusive interview.

Accord Seeks To Capitalize On Portfolio And Partnerships

Accord expects to maintain its historically high growth rates through a “holistic” approach to medicines that covers generics and biosimilars alongside more innovative products, with recent marketing alliances in Europe playing into the firm’s ambitions in the CNS area.

Related Content

Topics

UsernamePublicRestriction

Register

GB150399

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel